相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma
Norifumi Tsubokawa et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2016)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma
Yi-Chen Yeh et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2016)
Clinical Impact of Minimal Micropapillary Pattern in Invasive Lung Adenocarcinoma Prognostic Significance and Survival Outcomes
Geewon Lee et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Solid Component and Tumor Size Correlate With Prognosis of Stage IB Lung Adenocarcinoma
Songtao Xu et al.
ANNALS OF THORACIC SURGERY (2015)
Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival
Hideki Ujiie et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease
Alma D. Campos-Parra et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Predictive Value of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma in Tumor Recurrence and Patient Survival
Jung-Jyh Hung et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Micropapillary and solid subtypes of invasive lung adenocarcinoma: Clinical predictors of histopathology and outcome
Min Jae Cha et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2014)
A Comprehensive Investigation of Molecular Features and Prognosis of Lung Adenocarcinoma with Micropapillary Component
Yang Zhang et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma
Yang Zhang et al.
SCIENTIFIC REPORTS (2014)
Pattern in lung tumor pathology may predict recurrence
[Anonymous]
LUNG CANCER MANAGEMENT (2013)
Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients
Prudence A. Russell et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Impact of Micropapillary Histologic Subtype in Selecting Limited Resection vs Lobectomy for Lung Adenocarcinoma of 2cm or Smaller
Jun-ichi Nitadori et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival
Arne Warth et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases
Akihiko Yoshizawa et al.
MODERN PATHOLOGY (2011)
Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaive patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study
Giorgio V. Scagliotti et al.
EUROPEAN JOURNAL OF CANCER (2009)
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
Tudor Ciuleanu et al.
LANCET (2009)
The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies
Giorgio Scagliotti et al.
ONCOLOGIST (2009)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
Giorgio Vittorio Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer
DH Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
分享论文
